The adipocyte-derived hormone leptin is an important regulator of systemic energy metabolism. Transported via the circulation to the brain in proportion to fat mass, leptin promotes its biological action through activation of the long form of the leptin receptor (LepRb). Accordingly, binding of leptin to the extracellular domain of LepRb promotes transphosphorylation of the LepRb-associated Janus kinase 2 (JAK2), which in turn phosphorylates other tyrosine residues (Tyr 985 , Tyr 1077 , Tyr 1138 ) along the intracellular tail of LepRb in order to facilitate downstream signaling [1] . The protein tyrosine phosphatase 1B (PTP1B) is an important negative regulator of leptin action due to its ability to directly inhibit LepRb-Jak2 signaling ( Figure 1 ). The relevance of PTP1B to regulate energy metabolism was first shown in mice with global PTP1B deletion [2] and was later confirmed in a series of other studies. These whole body PTP1B deficient mice show decreased body weight, food intake and adiposity, leading to resistance to diet-induced obesity (DIO) and improved leptin sensitivity and glucose metabolism when exposed to a high-fat diet (HFD) [2] . Of appreciable note, mice with specific deletion of PTP1B in muscle, liver or adipose tissue show no overt changes in body weight, adiposity or glucose tolerance [3] [4] [5] . However, deletion of PTP1B specifically in the central nervous system (CNS) [6] , in LepRb-expressing cells [7] and POMC neurons [8,9] mimics the results observed in the global PTP1B deficient mice. These studies strongly support the relevance of central PTP1B signaling in regulating energy metabolism. It remains unclear, however, whether and to what This commentary refers to "Improved metabolic phenotype of hypothalamic PTP1B-deficiency is dependent upon the leptin receptor by Tsou et al
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